Novartis - Top 10 Layoffs of 2010

Company: Novartis
Layoffs: 1,400

Scoop: After much concern that Novartis would release Roche-esque layoffs, the company ended the year announcing 1,400 cuts from the sales department, all of which would be effective starting Jan. 1. The layoffs come primarily from the company's General Medicines sales force, as it prepares for the effects of numerous patent expirations. Instead, the company will focus its sales efforts on specialty drugs, according to a statement.

Novartis is still assessing its efficiency in sales, marketing and manufacturing, which could lead to more extensive job cuts in the coming years.

Novartis - Top 10 Layoffs of 2010
Read more on

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.